glp-1 obesity drug news today sep 30 2025 The latest patient isn't looking for a major life overhaul or a whole new body. Their goal? “To lose a few pounds for a big event or beach vacation,” says board-certified New GLP-1 Pill Foundayo (Orforglipron)

This review paper summarizes the research findings for NAD+ boosters and brain health, highlighting positive benefits for cognitive function and brain aging in animal models

(2024, April 23)

FIGURE 1 Activating the Transient Receptor Potential Vanilloid 1 and Cannabinoid 1 Receptors Acetaminophen is first metabolized to p -aminophenol, which easily crosses the blood-brain barrier and is converted to AM404 by fatty acid amide hydrolase ( N -acetyl- p -benzoquinoneimine (NAPQI), which also appears to produce analgesia by activating transient receptor potential ankyrin 1 receptors ( Similar to the brain, it is also known that the spinal cord, especially SG neurons, is critical to pain pathways, and modulates nociceptive transmission via primary afferent A- and C-fibers ( c-fos -positive immunoreactivity induced by non-noxious stimulation of the spinal cord in a rat model of neuropathic or inflammatory pain, and these responses are inhibited by TRPV1 or CB1 receptor antagonists ( in vivo and in vitro whole-cell patch-clamp recordings with nave rats ( in vivo and in vitro whole-cell patch-clamp recordings of SG neurons in the spinal cord dorsal horn and recorded the excitatory post-synaptic currents (EPSCs)

This single habit prevents the most serious dosing errors

Because these compounds sit outside regulated supply chains, purity and accurate labeling are not guaranteed by any oversight body

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences